| Dr Brittany Brooks, MD | |
|
1061 Harmon Ave, Fort Stewart, GA 31314-5641 | |
| (912) 435-6965 | |
| Not Available |
| Full Name | Dr Brittany Brooks |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 1061 Harmon Ave, Fort Stewart, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033553367 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 0101260896 (Virginia) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
In response to the H1N1 flu, most employees at U.S. businesses say their company took measures to protect them from illness, such as encouraging sick employees to stay home, according to a national poll of employees by researchers from the Harvard Opinion Research Program at Harvard School of Public Health.
Inspire Pharmaceuticals, Inc. announced today that the results from its first Phase 3 clinical trial with denufosol tetrasodium for cystic fibrosis (CF), TIGER-1, have been published in the peer-reviewed publication, American Journal of Respiratory and Critical Care Medicine (AJRCCM). Denufosol is an investigational, inhaled, novel ion channel regulator currently in Phase 3 clinical development for the treatment of CF.
United Spinal Association will host its inaugural Disability Leadership and Policy Summit on April 15th in Philadelphia, commemorating the 20th Anniversary of the Americans with Disabilities Act, which was signed into law on July 26, 1990 and prohibits discrimination based on disability. The law was amended in 2008 to offer more protection to disabled workers.
Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer's disease, a recent study from neuroscientists at the University of South Florida shows.
› Verified 4 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1578638425 PECOS PAC ID: 3779495858 Enrollment ID: O20040805001280 |
News Archive
In response to the H1N1 flu, most employees at U.S. businesses say their company took measures to protect them from illness, such as encouraging sick employees to stay home, according to a national poll of employees by researchers from the Harvard Opinion Research Program at Harvard School of Public Health.
Inspire Pharmaceuticals, Inc. announced today that the results from its first Phase 3 clinical trial with denufosol tetrasodium for cystic fibrosis (CF), TIGER-1, have been published in the peer-reviewed publication, American Journal of Respiratory and Critical Care Medicine (AJRCCM). Denufosol is an investigational, inhaled, novel ion channel regulator currently in Phase 3 clinical development for the treatment of CF.
United Spinal Association will host its inaugural Disability Leadership and Policy Summit on April 15th in Philadelphia, commemorating the 20th Anniversary of the Americans with Disabilities Act, which was signed into law on July 26, 1990 and prohibits discrimination based on disability. The law was amended in 2008 to offer more protection to disabled workers.
Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer's disease, a recent study from neuroscientists at the University of South Florida shows.
› Verified 4 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1073678637 PECOS PAC ID: 3779495858 Enrollment ID: O20100729000796 |
News Archive
In response to the H1N1 flu, most employees at U.S. businesses say their company took measures to protect them from illness, such as encouraging sick employees to stay home, according to a national poll of employees by researchers from the Harvard Opinion Research Program at Harvard School of Public Health.
Inspire Pharmaceuticals, Inc. announced today that the results from its first Phase 3 clinical trial with denufosol tetrasodium for cystic fibrosis (CF), TIGER-1, have been published in the peer-reviewed publication, American Journal of Respiratory and Critical Care Medicine (AJRCCM). Denufosol is an investigational, inhaled, novel ion channel regulator currently in Phase 3 clinical development for the treatment of CF.
United Spinal Association will host its inaugural Disability Leadership and Policy Summit on April 15th in Philadelphia, commemorating the 20th Anniversary of the Americans with Disabilities Act, which was signed into law on July 26, 1990 and prohibits discrimination based on disability. The law was amended in 2008 to offer more protection to disabled workers.
Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer's disease, a recent study from neuroscientists at the University of South Florida shows.
› Verified 4 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1366781700 PECOS PAC ID: 3779495858 Enrollment ID: O20130507000207 |
News Archive
In response to the H1N1 flu, most employees at U.S. businesses say their company took measures to protect them from illness, such as encouraging sick employees to stay home, according to a national poll of employees by researchers from the Harvard Opinion Research Program at Harvard School of Public Health.
Inspire Pharmaceuticals, Inc. announced today that the results from its first Phase 3 clinical trial with denufosol tetrasodium for cystic fibrosis (CF), TIGER-1, have been published in the peer-reviewed publication, American Journal of Respiratory and Critical Care Medicine (AJRCCM). Denufosol is an investigational, inhaled, novel ion channel regulator currently in Phase 3 clinical development for the treatment of CF.
United Spinal Association will host its inaugural Disability Leadership and Policy Summit on April 15th in Philadelphia, commemorating the 20th Anniversary of the Americans with Disabilities Act, which was signed into law on July 26, 1990 and prohibits discrimination based on disability. The law was amended in 2008 to offer more protection to disabled workers.
Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer's disease, a recent study from neuroscientists at the University of South Florida shows.
› Verified 4 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1497023188 PECOS PAC ID: 3779495858 Enrollment ID: O20131029000108 |
News Archive
In response to the H1N1 flu, most employees at U.S. businesses say their company took measures to protect them from illness, such as encouraging sick employees to stay home, according to a national poll of employees by researchers from the Harvard Opinion Research Program at Harvard School of Public Health.
Inspire Pharmaceuticals, Inc. announced today that the results from its first Phase 3 clinical trial with denufosol tetrasodium for cystic fibrosis (CF), TIGER-1, have been published in the peer-reviewed publication, American Journal of Respiratory and Critical Care Medicine (AJRCCM). Denufosol is an investigational, inhaled, novel ion channel regulator currently in Phase 3 clinical development for the treatment of CF.
United Spinal Association will host its inaugural Disability Leadership and Policy Summit on April 15th in Philadelphia, commemorating the 20th Anniversary of the Americans with Disabilities Act, which was signed into law on July 26, 1990 and prohibits discrimination based on disability. The law was amended in 2008 to offer more protection to disabled workers.
Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer's disease, a recent study from neuroscientists at the University of South Florida shows.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brittany Brooks, MD 1061 Harmon Ave, Fort Stewart, GA 31314-5641 Ph: (912) 435-6965 | Dr Brittany Brooks, MD 1061 Harmon Ave, Fort Stewart, GA 31314-5641 Ph: (912) 435-6965 |
News Archive
In response to the H1N1 flu, most employees at U.S. businesses say their company took measures to protect them from illness, such as encouraging sick employees to stay home, according to a national poll of employees by researchers from the Harvard Opinion Research Program at Harvard School of Public Health.
Inspire Pharmaceuticals, Inc. announced today that the results from its first Phase 3 clinical trial with denufosol tetrasodium for cystic fibrosis (CF), TIGER-1, have been published in the peer-reviewed publication, American Journal of Respiratory and Critical Care Medicine (AJRCCM). Denufosol is an investigational, inhaled, novel ion channel regulator currently in Phase 3 clinical development for the treatment of CF.
United Spinal Association will host its inaugural Disability Leadership and Policy Summit on April 15th in Philadelphia, commemorating the 20th Anniversary of the Americans with Disabilities Act, which was signed into law on July 26, 1990 and prohibits discrimination based on disability. The law was amended in 2008 to offer more protection to disabled workers.
Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer's disease, a recent study from neuroscientists at the University of South Florida shows.
› Verified 4 days ago
Jordan T Ochsner, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave Ste 1d03, Winn Army Community Hospital, Fort Stewart, GA 31314 Phone: 912-435-6633 Fax: 915-742-2653 | |
Michael David April, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-435-6633 | |
Marc F Wuerdeman, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-435-6965 | |
Dr. Todd Christopher Knudson, M.D., MPH; CPT MC FS General Practice Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Ste 1d03 Winn Army Community Hospital, Fort Stewart, GA 31314 Phone: 912-315-5510 | |
Dr. Kelly Denise Thomas, MD General Practice Medicare: May Accept Medicare Assignments Practice Location: 1061 Harmon Ave, Winn Army Community Hospital, Fort Stewart, GA 31314 Phone: 912-435-6965 | |
Kendra Parker-pitts, MD General Practice Medicare: Medicare Enrolled Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-435-6965 |